Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) (345072)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

Next deadline: May 13, 2023 (Letter of inquiry)

Later deadlines: Jun 13, 2023 (Full proposal), Oct 17, 2023 (Letter of inquiry), Nov 17, 2023 (Full proposal)

Grant amount: Up to US $900,000

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

NOTE: All applications are due by 5:00 PM local time of applicant organization. 

The goal of this FOA is to advance cancer model systems that recapitulate human immunity in the tumor microenvironment to improve the predictivity of immuno-oncology studies. Proposed research projects must focus on recapitulation of the human immune system in their proposed cancer model using human cells or tissues to regenerate and/or recapitulate the human immune system in in vivo or in vitro immuno-oncology models in a manner that matches or exceeds representation of the human immune system achieved with murine models developed using HFT. Models derived from genetically manipulated immune systems without introduction of human immune lineage cells will not be considered responsive.The FOA will utilize the R33 Exploratory/Developmental Grants Phase II research activity code.

Budgets are limited to $300,000 Direct Costs (excluding consortium F&A) per year. The maximum project period is three years.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.